Pharmaceutical composition for treating uterine disorders preferably uterine fibroids, adenomyosis, endometriosis, heavy menstrual bleeding, or pain, comprises dydrogesterone or its ester(s), aromatase inhibitor or its salts and anthelmintic agent or its salts along with one or more excipients
	RAI S K; KUMAR A; KUMAR R
	2023-09-18
专利权人	MANKIND PHARMA LTD (MANK-Non-standard)
申请日期	2023-09-18
专利号	IN202311062579-A
成果简介	NOVELTY - Pharmaceutical composition comprises dydrogesterone or its ester(s), aromatase inhibitor or its salts, and anthelmintic agent or its salts along with one or more excipients. USE - Pharmaceutical composition for treating uterine disorders preferably uterine fibroids, adenomyosis, endometriosis, heavy menstrual bleeding, or pain associated with uterine fibroids, endometriosis, or adenomyosis and other related disorders, lower back pain, abdominal pain, and hemostasis in the threatened abortion, female infertility, pain during menstruation, premenstrual syndrome. Test details are described but no results given. ADVANTAGE - The composition exhibits synergistic effect and significantly reduces the time required to treat and prevent the disorders related to uterus. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a kit comprising: (a) composition comprising dydrogesterone and excipients; (b) composition comprising letrozole and excipients; (c) composition comprising Anthelmintic agent and excipients, where the composition of dydrogesterone and letrozole are administered either simultaneously, concurrently, alternately and/or sequentially.
IPC 分类号	A61K-031/565 ; A61K-009/20 ; A61K-009/22 ; A61K-009/30 ; A61K-009/34 ; A61K-009/36 ; A61K-009/52 ; A61K-009/56
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20357
专题	中国科学院新疆生态与地理研究所
作者单位	MANKIND PHARMA LTD (MANK-Non-standard)
推荐引用方式 GB/T 7714	RAI S K,KUMAR A,KUMAR R. Pharmaceutical composition for treating uterine disorders preferably uterine fibroids, adenomyosis, endometriosis, heavy menstrual bleeding, or pain, comprises dydrogesterone or its ester(s), aromatase inhibitor or its salts and anthelmintic agent or its salts along with one or more excipients. IN202311062579-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。